Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem

Research Communications in Molecular Pathology and Pharmacology

Volumn 99, Issue 3, 1998, Pages 321-327

  Tanaka, Hikaru ^a   Matsui, Saiko ^a   Shigenobu, Koki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; DILTIAZEM; PROPRANOLOL;

ARTICLE; DRUG EFFECT; HEART CONTRACTION; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; DILTIAZEM; EPOPROSTENOL; GUINEA PIGS; HEART; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PLATELET AGGREGATION INHIBITORS; PROPRANOLOL; VASODILATOR AGENTS;

EID: 0031920544     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 2 analogue. Br. J. Pharmacol., 89: 703-711.
2. Araki, H. and Lefer, A. (1980). Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ. Res., 47: 757-763.
3. 2) increases left ventricular ejection fraction (LVEF). Prostaglandins Leukot. Essent. Fatty Acids., 36: 149-157.
4. 2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart. Adv. Prostaglandin Thrombxan Leukot. Res., 21: 939-942.
5. Grover, G.J. and Sleph, P.G. (1989). Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine. J. Cardiovasc. Pharmacol., 14: 98-104.
6. Lefer, A., Ogletree, M., Smith, J., Silver, M., Nicolau, K., Barnette, W. and Rasic, G. (1978). Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science, 200: 52-54.
7. Marie, P., Zannad, F., Parisot, M. and Royer, R. (1989). Role of ancillary properties of β-adrenoceptor antagonists in protecting the heart from anoxia. Eur. J. Pharmacol., 163: 337-343.
8. Melin, J. and Becker, L. (1983). Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction. J. Am. Coll. Cardiol 2: 279-286.
9. Nishio, S., Matsuura, H., Kanai, N., Fukatsu, Y., Hirano, T., Nishikawa, N., Kameoka, K. and Umetsu, T. (1988). The in vitro and ex vivo anti-platelet effect of TRK-100, a stable prostacyclin analog, in several species. Jpn. J. Pharmacol., 47: 1-9.
10. Ogletree, M., Lefer, A., Smith, J. and Nicolaou, K. (1979). Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur. J. Pharmacol., 56: 95-103.
11. Sim, A., McCraw, A., Cleland, M., Nishio, S. and Umetsu, T. (1985). Effects of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation. Arzneim-Forsch/Drug Res., 35: 1816-1818.
12. Tanaka, H., Matsui, S., Kawanishi, T. and Shigenobu, K. (1996). Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage. J Pharmacol. Exp. Ther., 278: 854-861.
13. Tanaka, H., Okazaki, K. and Shigenobu, K. (1996). Cardioprotective effects of NIP-121, a novel ATP sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium. J. Cardiovasc. Pharmacol., 27: 695-701.
14. 2+ current. Naunyn-Schmeid. Arch. Pharmacol., in press.
15. Tanonaka, K., Maruyama, Y. and Takeo, S. (1991). Beneficial effect of beraprost, a prostacyclin-mimetic agent on post hypoxic recovery of cardiac function and metabolism in rabbit isolated hearts. Br. J. Pharmacol., 104: 799-786.
16. Ueno, Y., Shigenobu, K. and Nishio, S. (1993). Effects of beraprost on the transmembrane potentials of guinea-pig ventricular muscles during normoxia and hypoxia-reoxygenation. Br. J. Pharmacol., 109: 1014-1019.
17. Ueno, Y., Shigenobu, K. and Nishio, S. (1994). Effect of beraprost sodium on changes in action potentials during hypoxia as compared with propranolol, diltiazem and glibenclamide in guinea-pig ventricular muscle. Arch. Int. Pharmacodyn. Ther., 382: 191-199.
18. 2 analogue. Jpn. J. Pharmacol., 43: 81-89.
19. Yui, Y., Nakajima, H., Kawai, C. and Muarakami, T. (1982). Prostacyclin therapy in patients with congestive heart failure. Am. J. Cardiol., 50: 320-328.
20. Yui, Y., Sakurai, T., Nakajima, H. and Kawai, C. (1984). Effect of prostacyclin and prazosin in the treatment of congestive heart failure, with special reference in the sympathetic nervous system. Jpn. Circ. J., 48: 365-373.